CoreAge Rx has first commercial placement. This is a curated comparison of prescribing services, a labeled prescription drug and a cysteamine cream—not a clinical league table.
Exact concentrations and treatment duration need individual confirmation.
The Spot Cream is marketed for melasma and other pigment concerns.
Patient-reported outcomes do not replace controlled comparative evidence.
Dark Spot Rx is a customized pigment treatment, with hydroquinone-free formulas also possible.
Not every formula contains hydroquinone; the brand name is not a fixed recipe.
A fixed three-drug cream with a specific short-term facial-melasma indication.
Not indicated for maintenance; the label has important population and use limits.
Studies of older 5% preparations are not automatically trials of today’s 7% formula.
Discoloration Defense publishes four highlighted ingredient percentages.
Appearance studies are not a head-to-head melasma treatment ranking.
Dark-spot marketing is not a diagnosis or a prescription treatment claim.